How big is the digital health market really?
Everything we know about the digital health market, in one place. Get our report whether you build or invest.
Summary
The global digital health market is about $420 billion today, with roughly $350 billion to $500 billion as the most defensible broad range.
The famous $181 billion versus $573 billion gap is mostly a definition problem, not a forecasting failure. Narrow estimates focus on patient-facing digital care and wellness, while broader ones pull in EHRs, analytics, connected devices, telehealth infrastructure and other health IT.
The cleanest anchor comes from recent broad-market estimates rather than from averaging every published TAM. Five comparable 2026 estimates cluster between $371.6 billion and $491.6 billion, with a median of $420.2 billion.
That still makes digital health surprisingly small beside healthcare itself. A $420 billion market is only around 4% of more than $10 trillion in annual global health spending, so digital penetration can rise substantially without digital health ever becoming most of healthcare.
The market is also less consumer-driven than the app-heavy image suggests. Enterprise software, telehealth infrastructure, hospital workflows, connected medical technology and clinical analytics account for a large share of commercial activity.
Telehealth has settled into a durable post-pandemic role rather than disappearing. U.S. claims data still put it around 5% of medical claim lines, with mental health accounting for a striking share of usage.
In mature markets, basic digitization is no longer the main story. U.S. EHR adoption is already close to saturation, which pushes new spending toward interoperability, workflow automation, cybersecurity, clinical decision support, patient communication and AI.
Wearables and remote monitoring are already large businesses, but they are also where double counting gets dangerous. The same revenue can appear inside wearable, remote-monitoring, medical-device and digital-health market estimates at the same time.
Venture funding is recovering, but the rebound is concentrated. More dollars are flowing into digital health even as deal counts stay relatively flat, which suggests investors are backing fewer companies with larger checks rather than broadly reopening the funding market.
AI is becoming one of the strongest new growth engines inside digital health, especially in documentation, clinical search, coding, diagnostics and physician workflows. The important economic shift is that AI can turn previously manual healthcare work into software-like revenue.
Twenty-percent-plus growth for the entire market looks aggressive. A low-to-mid-teens growth rate is easier to defend for broad digital health, while narrower categories such as clinical AI and digital therapeutics can grow much faster from smaller bases.
A $1 trillion digital health market is therefore plausible without heroic assumptions, but the timing depends heavily on scope. The bigger uncertainty is not whether digital health is commercially large; it is how much healthcare technology researchers choose to place inside the label.
Written by the New Market Pitch teamWe track new markets so founders and investors can move faster. About us
Price is often what holds a market back. See how fast that's changing in our digital health market report.
Why does the digital health market have a $181B answer and a $573B answer?
Digital health has a $181 billion answer and a $573 billion answer because those reports are counting very different things.
The gap is enormous. Statista currently expects $181.3 billion of digital health revenue in 2026. Grand View Research puts the same market at $420.2 billion. Fortune Business Insights says $491.6 billion. IMARC's latest estimate starts from $573.3 billion in 2025.
A normal forecasting disagreement cannot explain a 3x gap.
Statista uses a relatively tight consumer-facing definition built around Digital Treatment & Care, Online Doctor Consultations and Digital Fitness & Well-Being. Health IT sits elsewhere in its taxonomy. Fortune Business Insights includes EMR/EHR systems, e-prescribing, healthcare analytics, telehealth, mHealth and wearables. IMARC goes broad again with health IT systems, clinical decision support, trackers and telehealth.
So before asking how big digital health is, we have to decide which digital health we are talking about.
| Research firm | Latest base estimate | Base year | Broad scope |
|---|---|---|---|
| Statista | $181.3B | 2026 | Digital care, consultations, fitness and wellness |
| MarketsandMarkets | $199.1B | 2025 | Apps, telehealth, RPM, DTx, wearables and patient tools |
| The Business Research Company | $371.6B | 2026 | Telehealth, health IT, mHealth and analytics |
| Mordor Intelligence | $406.0B | 2026 | Telehealth, digital care, devices and health technology |
| Grand View Research | $420.2B | 2026 | Telehealth, mHealth, analytics, software and connected technology |
| Precedence Research | $483.1B | 2026 | Telehealth, EHRs, mHealth, wearables, AI and RPM |
| Fortune Business Insights | $491.6B | 2026 | Telehealth, health systems, analytics, wearables and mHealth |
| IMARC | $573.3B | 2025 | Health IT, clinical decision support, trackers, telehealth and mHealth |
What should actually count as digital health?
For this article, digital health should mean technology whose revenue comes directly from delivering, managing, monitoring or improving healthcare digitally.
That gives us a useful middle ground.
We count telehealth, remote patient monitoring, electronic health records, healthcare software, clinical analytics, connected health devices, digital therapeutics, digital care platforms and health-focused consumer technology.
We would leave out the full price of a drug simply because someone ordered it through an app. We also would not count an entire hospital bill because software helped schedule the appointment, or all of AWS revenue generated by servers that happen to host healthcare data.
Otherwise, digital health eventually becomes almost indistinguishable from healthcare itself.
The World Health Organization deliberately treats digital health very broadly because it is interested in how technology transforms health systems. That works for public policy. It works less well when we want to know how much revenue the commercial digital-health industry actually generates.
For market sizing, we need to count the technology and technology-enabled care layer without swallowing the underlying $10 trillion healthcare economy.
Still early or already mainstream? Our digital health market report answers that with real numbers.
So how big is the digital health market today?
We put the global digital health market at about $420 billion today.
That number comes from triangulating the current estimates rather than picking whichever market report gives us the biggest TAM.
Among five recent broad 2026 estimates we checked, The Business Research Company comes in at $371.6 billion, Mordor Intelligence at $406.0 billion, Grand View Research at $420.2 billion, Precedence Research at $483.1 billion and Fortune Business Insights at $491.6 billion.
The median is $420.2 billion.
That is unusually clean for a market with such messy definitions, and it gives us a much stronger anchor than quoting a single research firm.
We would use roughly $350 billion to $500 billion as the sensible broad range. Around $180 billion to $250 billion works for a much narrower patient-facing definition. Once health IT, connected medical technology and more digitally enabled services are included aggressively, estimates can move above $500 billion.
The best single number, as of now, is about $420 billion.
If you want more recent data on this point, please see our latest digital health market report.
Is a $420B digital health market actually big for healthcare?
A $420 billion digital health market is huge for technology, yet it still captures only around 4% of the money spent on healthcare worldwide.
The latest WHO expenditure database extends through 2023. Analysis of those data puts global health spending at around $10.6 trillion.
Our $420 billion digital-health estimate therefore represents roughly 4 cents for every dollar spent across the wider healthcare economy.
Hospitals, physicians, drugs, surgery and physical care still absorb vastly more money than the digital systems surrounding them.
The U.S. shows the same imbalance at an even more striking scale. CMS says American healthcare spending alone reached $5.3 trillion in 2024. That single country's healthcare bill is more than twelve times our estimate for the entire global digital-health industry.
Digital health can become much more important inside healthcare without ever needing to capture anything close to the majority of healthcare spending.
Is digital health mostly apps people use on their phones?
Today's digital health market is much more than health apps, with enterprise software, telehealth services, connected devices and clinical infrastructure taking a large share of the money.
Fortune Business Insights expects business-to-business customers to represent about 61% of its digital-health market in 2026.
Grand View Research reaches the same conclusion from another angle. Software represented 45.7% of its market in 2025, while telehealthcare represented 44.7% when the market was divided by technology. Those percentages describe different cuts of the market, so we cannot add them, but both point toward a large institutional business.
The contrast with Statista is useful. Statista's tighter consumer-heavy definition produces only $181 billion of revenue for 2026. Once researchers include hospital systems, clinical workflows, analytics and enterprise infrastructure, estimates quickly move toward $400 billion or more.
Governments are building the same infrastructure. WHO says 129 countries have now established national digital-health strategies.
Apps are the visible part of digital health. A lot of the actual spending happens much deeper inside hospitals, insurers, employers and medical practices.
How big is this market really? Our digital health market report sizes it with numbers you can check.
Did telehealth actually survive after the pandemic?
Telehealth clearly survived the pandemic reset and now looks like a permanent healthcare channel, especially for mental health.
FAIR Health's commercial-insurance data are useful because they measure actual claims rather than downloads or survey intentions. Through 2025, telehealth consistently accounted for around 5% of U.S. medical claim lines. In September, the figure was 5.0%.
Mental health dominates that activity. In the same FAIR Health data, 62.1% of patients with a telehealth claim in September had a mental-health diagnosis.
That is a much more durable footprint than the post-Covid narrative sometimes suggests.
Teladoc gives us another view. Revenue reached $2.53 billion in 2025, down only 2% from the previous year. The company is far removed from its pandemic hype cycle, yet billions of dollars are still flowing through the business.
Telehealth today looks more mature than explosive. Mental health, chronic care, routine follow-ups and convenient outpatient services have found lasting use cases, while the extraordinary pandemic growth rates have disappeared.
Are electronic health records still a growth story?
In the U.S., basic EHR adoption is essentially finished, and the next wave of digital-health spending is moving into the tools built around those records.
The latest figures from the Office of the National Coordinator for Health IT are close to saturation. More than 99% of non-federal acute-care hospitals had adopted a certified electronic health record by 2024, along with 91% of office-based physicians.
That changes what "digitizing healthcare" means.
A U.S. hospital rarely needs convincing to replace paper charts with a database today. The interesting spending now sits around interoperability, workflow automation, cybersecurity, revenue-cycle tools, clinical decision support, patient communication and AI.
Doximity is a good example of where this can go. The physician platform generated $644.9 million in its latest fiscal year and reported more than 800,000 active prescribers using its workflow tools in its fiscal fourth quarter.
Other countries are earlier in the cycle, so basic healthcare digitization still has room to expand globally. In mature healthcare systems, the bigger opportunity increasingly comes from making existing digital infrastructure useful rather than merely installing it.
If you want more recent data on this point, please see our latest digital health market report.
How much of digital health is wearables and remote monitoring?
Wearables and remote monitoring are already a multi-tens-of-billions business, and they are also one of the easiest places to accidentally inflate the digital-health TAM.
Statista put Digital Fitness & Well-Being revenue at roughly $66 billion in 2025. That includes products around fitness tracking, coaching and personal health monitoring.
At the clinical end, Dexcom generated about $4.66 billion in 2025 from continuous glucose-monitoring systems alone, up 16% in one year.
The line between those two worlds keeps getting thinner. Consumer devices increasingly monitor sleep, heart rhythm, temperature, glucose and other biomarkers, while clinical companies are making sensors smaller and easier to use outside hospitals.
The accounting problem is straightforward. A continuous glucose monitor can appear inside a wearable market, a remote-monitoring market, a diabetes-device market, a medical-device market and a digital-health market.
Those categories overlap heavily. Adding their published TAMs together would count the same revenue several times.
For us, wearables and remote monitoring belong inside digital health when their main economic purpose is health monitoring or care. We simply have to resist treating every adjacent market estimate as incremental revenue.
Sometimes the money comes before the interest, sometimes after. We compare both in our digital health market report.
Do actual digital health companies add up to a $420B market?
The digital-health companies people talk about most add up to only a small slice of $420 billion, which shows how fragmented this market really is.
We looked at eight public or recently public companies spanning virtual care, consumer health, mental health, diagnostics, physician software and connected monitoring.
Their latest full-year revenues add up to roughly $13.4 billion.
That is only about 3.2% of our $420 billion market estimate.
This is not a clean market-share calculation because some of these businesses mix software, devices and healthcare services. The comparison is useful for a different reason: digital health is clearly much larger than the familiar group of venture-backed names.
A huge amount of revenue sits with hospital-software vendors, medical-device companies, insurers, laboratories, healthcare-service groups and large incumbents such as Epic, Oracle, Philips, Siemens Healthineers, Apple and others.
| Company | Latest full-year revenue | What it tells us |
|---|---|---|
| Dexcom | $4.66B | Connected health monitoring can support a multibillion-dollar specialist |
| Teladoc Health | $2.53B | Virtual care remains a very large standalone business |
| Hims & Hers | $2.35B | Consumer digital healthcare can reach multibillion-dollar scale |
| LifeStance Health | $1.42B | Hybrid digital and physical mental healthcare is already substantial |
| Tempus AI | ~$1.27B | Diagnostics, health data and AI are converging quickly |
| Doximity | $644.9M | Physician workflow software can build a large, profitable niche |
| Omada Health | $260M | Virtual chronic-care platforms are scaling quickly |
| Amwell | $249.3M | Enterprise virtual-care infrastructure still generates meaningful revenue |
Is digital health funding booming again?
Digital health funding is recovering fast, but the comeback is concentrated in a relatively small group of companies.
Rock Health counted $14.2 billion of U.S. digital-health venture funding across 482 deals in 2025. Funding rose 35% from $10.5 billion the previous year even though the number of deals fell 5%.
That combination tells us more than the headline total.
The average deal jumped from $20.7 million to $29.3 million, while mega-rounds above $100 million absorbed 42% of all capital. Rock Health calculated that removing the nine companies that raised the most money would have pushed total 2025 funding below 2024.
The pattern is still visible this year.
Digital-health startups raised $7.4 billion across 244 U.S. deals in the first half of 2026, compared with $6.4 billion across 245 deals over the same period a year earlier. Almost exactly the same number of financings produced another $1 billion of capital.
Investors are paying more attention to digital health again. They are also much more selective about where the money goes.
Bigger than you think, or smaller? Our digital health market report puts real numbers on it.
Is AI actually making the digital health market bigger?
AI is already pulling more money into digital health, especially around clinical workflows, documentation, diagnostics and physician tools.
The adoption speed is unusually strong. An American Medical Association survey of almost 1,700 physicians found that 81% were using AI professionally in 2026. When the AMA first asked physicians the same question in 2023, the figure was 38%.
We can see the same shift inside companies.
Doximity reported more than 800,000 active prescribers using its workflow tools in its latest fiscal fourth quarter, and nearly half of those users were already using its clinical AI. Tempus AI generated roughly $1.27 billion of revenue in 2025, up about 83%, including roughly 30% organic growth after stripping out its Ambry acquisition.
Investors followed the usage. Rock Health found that AI-enabled companies represented half of U.S. digital-health funding deals in 2025 and captured 54% of all dollars raised.
Some of that money is moving from older software budgets into newer AI tools. The bigger opportunity comes when AI makes previously manual work cheap enough to turn into software: note-taking, coding, chart review, clinical search, patient messaging, triage and parts of diagnostics.
That expansion is already starting. AI is likely to become one of the main reasons digital health grows faster than healthcare spending overall during the next several years.
If you want more recent data on this point, please see our latest digital health market report.
Are digital therapeutics actually a big market today?
Digital therapeutics are growing quickly, but they are still a small corner of digital health at roughly $10 billion to $12 billion today.
Grand View Research estimated the market at $9.5 billion in 2025 and $12.0 billion in 2026.
Even the higher figure equals less than 3% of our $420 billion digital-health estimate.
The category does have companies showing real commercial traction. Omada Health increased revenue 53% to $260 million in 2025 and finished the year with 886,000 members, up 55%.
At the same time, digital therapeutics have already learned a hard lesson: clinical evidence alone does not guarantee reimbursement or a workable business model. Pear Therapeutics became the famous example when the prescription-digital-therapeutics pioneer entered bankruptcy in 2023.
The companies doing better today tend to combine software with ongoing care, employer or payer distribution, chronic-disease management and clear reimbursement economics.
Digital therapeutics can grow much faster than digital health overall for years and still remain a relatively small part of the total market.
A few players often take most of the market. Our digital health market report shows who's really in control.
Can digital health really keep growing 20% a year?
For the whole digital health market, we think low-to-mid-teens annual growth is more believable than 20%.
The published forecasts are all over the place.
Statista expects only 8.4% annual growth through 2031. Precedence Research says 10.8%. IMARC says 15%. The Business Research Company says 15.6%, and Mordor Intelligence says 16.9%.
At the aggressive end, Fortune Business Insights, Grand View Research and MarketsandMarkets all expect growth above 20%.
A lot of that disagreement comes straight back to definitions. Mature consumer products and established software pull growth downward. AI, remote monitoring, emerging markets and newer care models pull it upward.
There is also a simple arithmetic problem with keeping 20% growth going for too long. A $420 billion market compounding at 20% annually would exceed $1 trillion in about five years and pass $2.5 trillion roughly five years after that.
That outcome is possible under a very expansive definition, but it requires digital technology to absorb healthcare budgets at an extraordinary pace.
We would use roughly 12% to 15% as a stronger base case for broad digital health today, with individual categories such as clinical AI or digital therapeutics capable of growing much faster.
| Research firm | Starting point | Forecast | Published CAGR |
|---|---|---|---|
| Statista | $181.3B in 2026 | $271.8B in 2031 | 8.4% |
| Precedence Research | $483.1B in 2026 | $1.17T in 2035 | 10.8% |
| IMARC | $573.3B in 2025 | $2.09T in 2034 | 15.0% |
| The Business Research Company | $371.6B in 2026 | $664.7B in 2030 | 15.6% |
| Mordor Intelligence | $406.0B in 2026 | $884.4B in 2031 | 16.9% |
| Fortune Business Insights | $491.6B in 2026 | $2.35T in 2034 | 21.6% |
| Grand View Research | $420.2B in 2026 | $1.83T in 2033 | 23.4% |
| MarketsandMarkets | $199.1B in 2025 | $573.5B in 2030 | 23.6% |
If you want more recent data on this point, please see our latest digital health market report.
Could digital health really become a $1 trillion market?
A broad digital health market can realistically reach $1 trillion, with a seven-to-eight-year path looking more believable than an immediate AI-driven jump.
Starting from our $420 billion estimate, the maths are straightforward.
At 12% annual growth, digital health reaches $1 trillion in roughly eight years. At 15%, it takes a little over six years. At 20%, the threshold arrives in less than five.
The first two paths look much easier to defend.
Healthcare still has enormous amounts of administrative work, monitoring, communication and clinical workflow that software can absorb. AI is speeding that process up. Remote care is already established. EHR infrastructure is widespread in mature markets. Emerging healthcare systems are still digitizing.
As seen above, though, the definition can move the trillion-dollar date by years. Statista's narrow market reaches only $271.8 billion in 2031. Grand View Research's much broader definition goes beyond $1.8 trillion by 2033.
So $1 trillion is a believable destination for broad digital health. The interesting question is how much of that growth comes from genuinely new revenue and how much comes from researchers gradually pulling more healthcare technology inside the digital-health label.
Unit economics can make or break a business model. See who keeps what in our digital health market report.
How big is the digital health market really?
Our best current estimate is about $420 billion globally, with roughly $350 billion to $500 billion as the most defensible broad range.
That answer comes from the evidence rather than from averaging every TAM we could find.
Five recent broad 2026 estimates cluster between $371.6 billion and $491.6 billion, and their median lands almost exactly at $420 billion. A narrower consumer and patient-facing definition gives us something closer to $180 billion to $250 billion. Very broad definitions can already push the number above $500 billion.
We would therefore use $420 billion when somebody asks for one number.
At that size, digital health already represents a major global technology industry. Yet it captures only around 4% of the more than $10 trillion spent on healthcare worldwide, leaving plenty of room for software, AI, connected monitoring and digitally delivered care to take a larger share.
The market can eventually cross $1 trillion without requiring a fantasy scenario. Sustained growth in the low-to-mid teens would be enough.
The clearest answer today is around $420 billion, growing quickly, with the biggest uncertainty coming from what people choose to call digital health rather than whether a large commercial market actually exists.
If you want more recent data on this point, please see our latest digital health market report.
Our methodology
This analysis estimates how big the digital health market really is by comparing published market sizes with the definitions behind them, then checking whether the resulting range fits observable activity across healthcare systems, companies, utilization, funding and technology adoption.
We did not average narrow and broad market estimates as though they measured the same thing. Statista's consumer-heavy definition was treated separately from broader definitions that include health IT, EHRs, analytics, telehealth infrastructure, connected devices and other enterprise healthcare technology.
For the central market-size anchor, we focused on five recent broad 2026 estimates from The Business Research Company, Mordor Intelligence, Grand View Research, Precedence Research and Fortune Business Insights. Their range is $371.6 billion to $491.6 billion, and the median is $420.2 billion.
We used the wider set of estimates from Statista, MarketsandMarkets, IMARC and the other research firms to understand how much the answer moves when the scope changes. Those figures are useful as boundary markers, not as interchangeable observations from one perfectly defined market.
Overlapping categories were kept separate when necessary. Telehealth, wearables, remote monitoring, digital therapeutics, healthcare software and connected medical devices can appear in several market classifications at once, so their published TAMs were not simply added together.
We then checked the market estimate against real activity. WHO and CMS data provide the scale of global and U.S. healthcare spending; U.S. health-IT data show how mature EHR adoption has become; FAIR Health provides claims-based telehealth utilization; and WHO's digital-health strategy work gives international adoption context.
Company results were used as commercial reality checks rather than as a bottom-up market total. Dexcom, Teladoc, Hims & Hers, LifeStance Health, Tempus AI, Doximity, Omada Health and Amwell span different parts of digital health, but several mix software, devices and healthcare services, so their revenues are not clean market-share measures.
For current growth signals, we used Rock Health's U.S. digital-health funding data and the American Medical Association's physician AI survey. Those sources help test whether capital and adoption are accelerating in the parts of the market most likely to drive the next leg of growth.
Forecasts were also checked mathematically. We compared published CAGRs with what they imply for a roughly $420 billion starting market, which is why the article treats low-to-mid-teens growth as a more defensible broad-market base case than assuming 20% or more can persist for many years.
Key sources used for this analysis include: Statista's Digital Health market outlook, MarketsandMarkets' Digital Health Market, The Business Research Company's Digital Health Global Market Report, Mordor Intelligence's Digital Health Market, Grand View Research's Digital Health Market, Precedence Research's Digital Health Market, Fortune Business Insights' Digital Health Market, and IMARC's Global Digital Health Market.
System, adoption and company evidence came from WHO's Global Health Expenditure Database, CMS National Health Expenditure Accounts, U.S. national EHR adoption data, WHO's digital-health strategy update, FAIR Health's telehealth claims analysis, Rock Health's 2025 funding overview, and the AMA's 2026 physician AI survey.
Commercial evidence came from Dexcom's FY2025 results, Doximity's FY2026 results, Tempus AI's FY2025 results, Omada Health's FY2025 results, and Grand View Research's Digital Therapeutics Market.
Want to know which startups could overtake the giants next? It's all in our digital health market report.
Written by the New Market Pitch teamWe track new markets so founders and investors can move faster. About us